Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
P D Cotter, … , L Wong, D F Bishop
P D Cotter, … , L Wong, D F Bishop
Published October 1, 1995
Citation Information: J Clin Invest. 1995;96(4):2090-2096. https://doi.org/10.1172/JCI118258.
View: Text | PDF
Research Article

Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.

  • Text
  • PDF
Abstract

Authors

P D Cotter, A May, E J Fitzsimons, T Houston, B E Woodcock, A I al-Sabah, L Wong, D F Bishop

×

Total citations by year

Year: 2024 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2009 2008 2007 2006 2004 2003 2002 2000 1999 1998 1997 1995 1949 Total
Citations: 1 4 2 1 1 3 4 3 4 3 1 7 5 1 3 3 5 1 3 6 3 3 8 4 1 1 81
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (81)

Title and authors Publication Year
An erythroid-specific lentiviral vector improves anemia and iron metabolism in a new model of XLSA
Castruccio Castracani C, Breda L, Papp TE, Guerra A, Radaelli E, Assenmacher CA, Finesso G, Mui BL, Tam YK, Fontana S, Riganti C, Fiorito V, Petrillo S, Tolosano E, Parhiz H, Rivella S
Blood 2024
Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia
Y Morimoto, K Chonabayashi, H Kawabata, C Okubo, M Yamasaki-Morita, M Nishikawa, M Narita, A Inagaki, K Nakanishi, M Nagao, A Takaori-Kondo, Y Yoshida
Blood Advances 2022
Structural basis for dysregulation of aminolevulinic acid synthase in human disease
J Taylor, B Brown
The Journal of biological chemistry 2022
Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis
K Ono, T Fujiwara, K Saito, H Nishizawa, N Takahashi, C Suzuki, T Ochi, H Kato, Y Ishii, K Onodera, S Ichikawa, N Fukuhara, Y Onishi, H Yokoyama, R Yamada, Y Nakamura, K Igarashi, H Harigae
Scientific Reports 2022
Regulation of Heme Synthesis by Mitochondrial Homeostasis Proteins
Yien YY, Perfetto M
Frontiers in Cell and Developmental Biology 2022
X-linked sideroblastic anaemia in a female fetus: a case report and a literature review
D Nzelu, P Shangaris, L Story, F Smith, C Piyasena, J Alamelu, A Elmakky, M Pelidis, R Mayhew, S Sankaran
BMC Medical Genomics 2021
A hemizygous p.R204Q mutation in the ALAS2 gene underlies X-linked sideroblastic anemia in an adult Chinese Han man
J Huang, M Ge, Y Shao, M Wang, P Jin, J Huo, X Li, J Zhang, N Nie, Y Zheng
BMC Medical Genomics 2021

Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options


G Abu-Zeinah, MT DeSancho
Journal of blood medicine 2020
Identification of a novel heterozygous ALAS2 mutation in a young Chinese female with X-linked sideroblastic anemia
Y Qiu, H Cai, L Cui, Y Liu, Y Wang, J Li, X Cao
Annals of Hematology 2019
Sex disparity in cancer: roles of microRNAs and related functional players
A Carè, M Bellenghi, P Matarrese, L Gabriele, S Salvioli, W Malorni
Cell Death and Differentiation 2018
Mutation Analysis of X-linked Sideroblastic Anemia in a 12-Month-Old Boy by Massively Parallel Sequencing
HJ Yu, YJ Lee, JW Shim, DS Kim, JY Shim, MS Park, HY Woo, H Park, HL Jung, MJ Kwon
Annals of Laboratory Medicine 2018
Molecular pathophysiology and genetic mutations in congenital sideroblastic anemia
T Fujiwara, H Harigae
Free radical biology & medicine 2018
Iron metabolism in erythroid cells and patients with congenital sideroblastic anemia
K Furuyama, K Kaneko
International Journal of Hematology 2017
Iron regulatory protein (IRP)-iron responsive element (IRE) signaling pathway in human neurodegenerative diseases
ZD Zhou, EK Tan
Molecular Neurodegeneration 2017
A novel heterozygous ALAS2 mutation in a female with macrocytic sideroblastic anemia resembling myelodysplastic syndrome with ring sideroblasts: a case report and literature review
T Fujiwara, N Fukuhara, S Ichikawa, M Kobayashi, Y Okitsu, Y Onishi, K Furuyama, H Harigae
Annals of Hematology 2017
Delayed diagnosis of congenital sideroblastic anemia
G Abu-Zeinah, M Al-Kawaaz, J Geyer, MT DeSancho
Seminars in Hematology 2017
Lethal ALAS2 mutation in males X-linked sideroblastic anaemia
C Rose, I Callebaut, L Pascal, C Oudin, M Fournier, L Gouya, A Lambilliotte, C Kannengiesser
British Journal of Haematology 2016
Sideroblastic anemia: functional study of two novel missense mutations in ALAS2
M Méndez, MI Moreno-Carralero, M Morado-Arias, MC Fernández-Jiménez, SI la Iñigo, MJ Morán-Jiménez
Molecular Genetics & Genomic Medicine 2016
[Genetic diagnosis of a Chinese pedigree with X-Linked sideroblastic anemia: a case report and literature review]
Changming Chen, Qiulan Ding, Yeling Lu, Jing Dai, Xuefeng Wang, Xiaodong Xi, Hongli Wang
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2016
Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt Conformational Equilibrium and Enhance Product Release
EJ Fratz, J Clayton, GA Hunter, S Ducamp, L Breydo, VN Uversky, JC Deybach, L Gouya, H Puy, GC Ferreira
Biochemistry 2015
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
DP Steensma, R Bejar, S Jaiswal, RC Lindsley, MA Sekeres, RP Hasserjian, BL Ebert
Blood 2015
Murine erythroid 5-aminolevulinate synthase: Adenosyl-binding site Lys221 modulates substrate binding and catalysis
BM Stojanovski, GC Ferreira
FEBS Open Bio 2015
Stochastic epigenetic mutations (DNA methylation) increase exponentially in human aging and correlate with X chromosome inactivation skewing in females
Davide Gentilini, Paolo Garagnani, Serena Pisoni, Maria Giulia Bacalini, Luciano Calzari, Daniela Mari, Giovanni Vitale, Claudio Franceschi, Anna Maria Di Blasio
Aging 2015
A Novel Hemizygous I418S Mutation in the ALAS2 Gene in a Young Korean Man with X-Linked Sideroblastic Anemia
SY Moon, IJ Jun, JE Kim, SJ Lee, HK Kim, SS Yoon
Annals of Laboratory Medicine 2014
The chaperone role of the pyridoxal 5′-phosphate and its implications for rare diseases involving B6-dependent enzymes
B Cellini, R Montioli, E Oppici, A Astegno, CB Voltattorni
Clinical Biochemistry 2014
Microcytic anemia in a pregnant woman: beyond iron deficiency
N Rollón, MC Fernández-Jiménez, MI Moreno-Carralero, MJ Murga-Fernández, MJ Morán-Jiménez
International Journal of Hematology 2014
Multiple mechanisms of action of pyridoxine in primary hyperoxaluria type 1
S Fargue, G Rumsby, CJ Danpure
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2013
Age-dependent skewing of X chromosome inactivation appears delayed in centenarians' offspring. Is there a role for allelic imbalance in healthy aging and longevity?
D Gentilini, D Castaldi, D Mari, D Monti, C Franceschi, AM di Blasio, G Vitale
Aging Cell 2012
The carboxyl-terminal region of erythroid-specific 5-aminolevulinate synthase acts as an intrinsic modifier for its catalytic activity and protein stability
S Kadirvel, K Furuyama, H Harigae, K Kaneko, Y Tamai, Y Ishida, S Shibahara
Experimental Hematology 2012
Dysplasia Has A Differential Diagnosis: Distinguishing Genuine Myelodysplastic Syndromes (MDS) From Mimics, Imitators, Copycats and Impostors
DP Steensma
Current Hematologic Malignancy Reports 2012
Iron chelation therapy for a case of transfusion-independent MDS-RARS with significant iron overload
H Ohashi, K Arita, Y Suzuki, A Tomita, T Naoe, A Hattori, Y Tatsumi, K Kato, H Nagai
International Journal of Hematology 2012
Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS)
R Ohba, K Furuyama, K Yoshida, T Fujiwara, N Fukuhara, Y Onishi, A Manabe, E Ito, K Ozawa, S Kojima, S Ogawa, H Harigae
Blut Zeitschrift für Blutforschung 2012
X-linked sideroblastic anemia due to carboxyl-terminal ALAS2 mutations that cause loss of binding to the β-subunit of succinyl-CoA synthetase (SUCLA2)
DF Bishop, V Tchaikovskii, AV Hoffbrand, ME Fraser, S Margolis
The Journal of biological chemistry 2012
X-linked Sideroblastic Anemia Due to Carboxyl-terminal ALAS2 Mutations That Cause Loss of Binding to the β-Subunit of Succinyl-CoA Synthetase (SUCLA2)*
DF Bishop, V Tchaikovskii, AV Hoffbrand, ME Fraser, S Margolis
The Journal of biological chemistry 2012
Ring sideroblasts and sideroblastic anemias
M Cazzola, R Invernizzi
Haematologica 2011
Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations
S Ducamp, C Kannengiesser, M Touati, L Garçon, A Guerci-Bresler, JF Guichard, C Vermylen, J Dochir, HA Poirel, F Fouyssac, L Mansuy, G Leroux, G Tertian, R Girot, H Heimpel, T Matthes, N Talbi, JC Deybach, C Beaumont, H Puy, B Grandchamp
Human Mutation 2011
Lack of efficacy of pyridoxine (vitamin B6) treatment in acquired idiopathic sideroblastic anaemia, including refractory anaemia with ring sideroblasts
LM Kreuziger, AP Wolanskyj, CA Hanson, DP Steensma
European Journal of Haematology 2011
Sideroblastic anemia
A May
Blood and Bone Marrow Pathology 2011
Iron Physiology and Pathophysiology in Humans
GJ Anderson, GD McLaren
2011
Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment
C Camaschella
Seminars in Hematology 2009
Recent advances in the understanding of inherited sideroblastic anaemia
C Camaschella
British Journal of Haematology 2008
Identification of a Hemizygous R170H Mutation in theALAS2Gene in a Young Male Patient with X-linked Sideroblastic Anemia
HS Choung, HJ Kim, CW Jung, SH Kim
The Korean Journal of Hematology 2008
Abeloff's Clinical Oncology
ER Fearon, GT Bommer
Abeloff's Clinical Oncology 2008
A skewed view of X-chromosome inactivation
Jakub Minks, Wendy P. Robinson, Carolyn J. Brown
Journal of Clinical Investigation 2007
X-linked clonality testing: interpretation and limitations
GL Chen, JT Prchal
Blood 2007
Candidate gene mutation analysis in idiopathic acquired sideroblastic anemia (refractory anemia with ringed sideroblasts)
DP Steensma, KA Hecksel, JC Porcher, TL Lasho
Leukemia Research 2007
B6-responsive disorders: A model of vitamin dependency
PT Clayton
Journal of Inherited Metabolic Disease 2006
Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity
K Furuyama, H Harigae, T Heller, BC Hamel, EI Minder, T Shimizu, T Kuribara, N Blijlevens, S Shibahara, S Sassa
European Journal of Haematology 2006
X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns
M Aivado, N Gattermann, A Rong, AA Giagounidis, WC Prall, A Czibere, B Hildebrandt, R Haas, SS Bottomley
Blood Cells, Molecules, and Diseases 2006
Microcytosis in agnogenic myeloid metaplasia: Prevalence and clinical correlates
A Tefferi, D Dingli, CY Li, RA Mesa
Leukemia Research 2006
The Myelodysplastic Syndromes: Diagnosis and Treatment
DP Steensma, JM Bennett
Mayo Clinic Proceedings 2006
Pediatric Bone Marrow
L Penchansky
2004
A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia
S Bekri, A May, PD Cotter, AI Al-Sabah, X Guo, GS Masters, DF Bishop
Blood 2003
Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
D Bowen, D Culligan, S Jowitt, S Kelsey, G Mufti, D Oscier, J Parker
British Journal of Haematology 2003
Late-onset X-linked sideroblastic anemia following hemodialysis
K Furuyama, H Harigae, C Kinoshita, T Shimada, K Miyaoka, C Kanda, Y Maruyama, S Shibahara, S Sassa
Blood 2003
The genetics of inherited sideroblastic anemias
MD Fleming
Seminars in Hematology 2002
Anemias Sideroblásticas
A Cánovas, R la Prieta, JJ Alonso, C Ruiz, T Pereira, C Aguirre
Gaceta Médica de Bilbao 2002
A novel mutation in exon 5 of the ALAS2 gene results in X-linked sideroblastic anemia
MT Hurford, C Marshall-Taylor, SL Vicki, JZ Zhou, LM Silverman, WN Rezuke, A Altman, GJ Tsongalis
Clinica Chimica Acta 2002
Erythroblast Iron Metabolism in Sideroblastic and Sideropenic States
LA McLintock, EJ Fitzsimons
Hematology 2002
High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms
BN Ames, I Elson-Schwab, EA Silver
The American journal of clinical nutrition 2002
Absent phenotypic expression of X-linked sideroblastic anemia in one of 2 brothers with a novel ALAS2 mutation
M Cazzola, A May, G Bergamaschi, P Cerani, S Ferrillo, DF Bishop
Blood 2002
Interaction between succinyl CoA synthetase and the heme-biosynthetic enzyme ALAS-E is disrupted in sideroblastic anemia
K Furuyama, S Sassa
Journal of Clinical Investigation 2000
From sideroblastic anemia to the role of mitochondrial DNA mutations in myelodysplastic syndromes
N Gattermann
Leukemia Research 2000
Familial-skewed X-chromosome inactivation as a predisposing factor for late-onset X-linked sideroblastic anemia in carrier females
M Cazzola, A May, G Bergamaschi, P Cerani, V Rosti, DF Bishop
Blood 2000
A novel mutation of the erythroid-specific delta-aminolaevulinate synthase gene in a patient with X-linked sideroblastic anaemia
H Harigae, K Furuyama, A Kimura, K Neriishi, N Tahara, M Kondo, N Hayashi, M Yamamoto, S Sassa, T Sasaki
British Journal of Haematology 1999
Metachromatic Leukodystrophy: Subtype Genotype/Phenotype Correlations and Identification of Novel Missense Mutations (P148L and P191T) Causing the Juvenile-Onset Disease
Y Qu, E Shapira, RJ Desnick
Molecular Genetics and Metabolism 1999
Four New Mutations in the Erythroid-Specific 5-Aminolevulinate Synthase (ALAS2) Gene Causing X-Linked Sideroblastic Anemia: Increased Pyridoxine Responsiveness After Removal of Iron Overload by Phlebotomy and Coinheritance of Hereditary Hemochromatosis
PD Cotter, A May, L Li, AI Al-Sabah, EJ Fitzsimons, M Cazzola, DF Bishop
Blood 1999
Hereditary sideroblastic anaemia due to a mutation in exon 10 of the erythroid 5-aminolaevulinate synthase gene
Edgar, Wickramasinghe
British Journal of Haematology 1998
R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity
K Furuyama, R Uno, A Urabe, N Hayashi, H Fujita, M Kondo, S Sassa, M Yamamoto
British Journal of Haematology 1998
Sideroblastic anemias: Variations on imprecision in diagnostic criteria, proposal for an extended classification of sideroblastic anemias
S Koc, JW Harris
American Journal of Hematology 1998
X-linked sideroblastic anaemia due to a mutation in the erythroid 5-aminolaevulinate synthase gene leading to an arginine170 to leucine substitution
AJ Edgar, HM Vidyatilake, SN Wickramasinghe
European Journal of Haematology 1998
X-Linked Wiskott–Aldrich Syndrome in a Girl
O Parolini, G Ressmann, OA Haas, J Pawlowsky, H Gadner, W Knapp, W Holter
New England Journal of Medicine 1998
Case 37-1998 : A 41-Year-Old Woman with Anemia and Severe Thrombocytopenia
RC Cabot, RE Scully, EJ Mark, WF McNeely, SH Ebeling, WC Aird, WM Kettyle
New England Journal of Medicine 1998
Pathogenetic Aspects of Myelodysplastic Syndromes
DJ Culligan
Hematology 1998
Deficient Heme and Globin Synthesis in Embryonic Stem Cells Lacking the Erythroid-Specific δ-Aminolevulinate Synthase Gene
H Harigae, N Suwabe, PH Weinstock, M Nagai, H Fujita, M Yamamoto, S Sassa
Blood 1998
Alterations in growth, haematopoiesis and serum chemistry profiles infitness 1 4226SB mutant mice
AE Schultze, DO Schaeffer, MD Potter, DK Johnson
Comparative Haematology International 1997
Identification of an arginine452 to histidine substitution in the erythroid 5-aminolaevulinate synthetase gene in a large pedigree with X-linked hereditary sideroblastic anaemia
AJ Edgar, MS Losowsky, JS Noble, SN Wickramasinghe
European Journal of Haematology 1997
Pyridoxine Refractory X-Linked Sideroblastic Anemia Caused by a Point Mutation in the Erythroid 5-Aminolevulinate Synthase Gene
K Furuyama, H Fujita, T Nagai, K Yomogida, H Munakata, M Kondo, A Kimura, A Kuramoto, N Hayashi, M Yamamoto
Blood 1997
Heteroplasmic Point Mutations of Mitochondrial DNA Affecting Subunit I of Cytochrome c Oxidase in Two Patients With Acquired Idiopathic Sideroblastic Anemia
N Gattermann, S Retzlaff, YL Wang, G Hofhaus, J Heinisch, C Aul, W Schneider
Blood 1997
Late-onset hereditary anemia: why the delay?
JP Kushner
Journal of Clinical Investigation 1995
Hematology
JJ Shea, JJ Shea
The Laryngoscope 1949

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts